miR-34b |
p53 effector |
Down |
Mouse lung |
Izzotti et al. 2011 |
miR-421 |
Targets SMAD4, polycomb gene CBX7, ATM
|
miR-450b |
No validated targets |
miR-466 |
No validated targets |
miR-469 |
Mouse miR not validated |
miR-135b |
Inflammation, oxidative stress |
Up |
Mouse lung |
Halappanavar et al. 2013 |
miR-206 |
Targets SERP1, BDNF, FOXP1
|
Up |
Rat serum |
Wu et al. 2013 |
miR-133b |
Targets LAG1, PTBP2
|
miR-20b |
Hypoxia |
Down |
Mouse lung and plasma |
Huang et al. 2012 |
miR-30e |
Targets UBC9, UBE21, MUC17
|
miR-125b |
Targets p53, stress response |
miR-128 |
Apoptosis |
let-7a |
Cell proliferation, angiogenesis |
Down |
Mouse lung |
Izzotti et al. 2009 |
let-7b |
Cell proliferation, angiogenesis |
let-7f |
Cell proliferation, angiogenesis |
miR-26a |
Transforming growth factor expression |
miR-30b |
Cell adhesion, stress response |
miR-30c |
Cell cycle, oncogene activation |
miR-34b |
p53 effector |
miR-99b |
Apoptosis |
miR-122a |
Stress response |
miR-124a |
Stress response, cell growth and differentiation |
miR-125a |
Oncogene activation, ROS |
miR-125b |
Targets p53, stress response |
miR-140 |
p53 effector |
miR-192 |
Oncogene activation |
miR-431 |
Protein repair, oncogene activation |
|
|
|
miR-92b |
Tumor suppressomiR |
Down |
Mouse serum |
Yuchuan et al. 2014 |
miR-668 |
Inflammation |
miR-700 |
Inflammation |
Let-7e |
Apoptosis |
Up |
Mouse serum |
Yuchuan et al. 2014 |
miR-19a |
OncomiR |
miR-142 |
Immunology |
miR-191 |
OncomiR |
miR-350 |
Unknown |
Abbreviations: oncomiR, miR with oncogenic properties; ROS, reactive oxygen species; suppressomiR, tumor suppresor miR. |